Preclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Spontaneous Canine Cancer: Results of a Phase I Study

por London, Cheryl A., Bernabe, Luis Feo, Barnard, Sandra, Kisseberth, William C., Borgatti, Antonella, Henson, Mike, Wilson, Heather, Jensen, Kiersten, Ito, Daisuke, Modiano, Jaime F., Bear, Misty D., Pennell, Michael L., Saint-Martin, Jean-Richard, McCauley, Dilara, Kauffman, Michael, Shacham, Sharon
Publicado 2014